BRH Wealth
Download Mobile Trading App
As on 05 Dec 2019
Affle India

Affle India announced the launch of ‘Vizury Engage360' an omnichannel marketing platform to help marketers unify their communication across connected channels and devices.

Vizury Engage360 aims to simplify the life of a digital marketer by connecting all devices and channels over its unified platform. This would allow marketers to craft unique consumer journeys to drive higher conversions and ROI powered by AI and ML algorithms.

Akme Star Hou. F

Akme Star Housing Finance has opened a branch office in Pune at the following address -

208, 2nd floor, Patil Plaza, Mitra Mandal Chowk, Parvati Pune - 411 009, Maharashtra.

Ansal Housing

Ansal Housing announced that Enchant Constructions ceases to be the wholly owned subsidiary of the company with effect from 05 December 2019.

Ansal Properties

Ansal Properties & Infrastructure announced that Dr. Lalit Bhasin, Non Executive Independent Director has resigned with effect from 04 December 2019.

Arshiya

Arshiya will hold a meeting of the Board of Directors of the Company on 7 December 2019.

Bank of Baroda

The Capital Rising Committee of Bank of Baroda at its meeting held on 05 December 2019 has approved the issuance of Basel III Compliant AT 1 Bonds for aggregate total size not exceeding Rs 1850 crore with base issue size of Rs 500 crore and a green shoe option to retain oversubscription up to Rs 1350 crore.

Bartronics India

Bartronics India announced that the powers of the Board of Directors stands suspended and vested with Chinnam Poorna Chandra Rao appointed as the IRP with respect to the company and initiation of Corporate Insolvency Resolution Process under IBC Code with effect from 02 December 2019.

Bharti Infra.

Bharti Infratel will hold a meeting of the Board of Directors of the Company on 10 December 2019.

Cadila Health.

Zydus Cadila announced that it has filed the NDA of Saroglitazar Mg in Non-alcoholic Steatohepatitis (NASH) with the Drug Controller General of India (DCGI).

NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for the treatment of NASH. Starting with fat accumulation in liver, this condition can progress to cirrhosis and liver failure. NASH ranks as one of the major causes of cirrhosis, behind hepatitis C and alcoholic liver disease. Liver transplantation is the only option for managing advanced cirrhosis with liver failure.

Saroglitazar Magnesium was launched in India during September 2013, for the treatment of hypertriglyceridemia and diabetic dyslipidemia in patients with type-2 diabetes not controlled by statins. Saroglitazar Mg has demonstrated beneficial effects in NASH animal models. Saroglitazar Mg favorably affects all components of NASH including steatosis, ballooning, inflammation and fibrosis in NASH models. Saroglitazar Mg has previously demonstrated improvement in both liver enzymes along with favorable effects on lipid and glycemic indices in patients with nonalcoholic fatty liver disease in Phase II clinical trials.

Zydus had also achieved positive results in EVIDENCES II Phase 3 biopsy-driven trial of Saroglitazar 4 mg versus Placebo in patients with Non-Alcoholic SteatoHepatitis. The primary endpoint evaluated the histological improvement of NASH using liver biopsy at the end of 52 weeks. Separately, the results of EVIDENCES IV trial of Saroglitazar Mg in patients with NASH were presented as a Late Breaker at The Liver Meeting® 2019, the annual meeting of the American Association for the Study of Liver Diseases.

Capital Trust

Capital Trust will hold a meeting of the Board of Directors of the Company on 12 December 2019.

Caplin Point Lab

Caplin Point Laboratories announced the sad demise of Dr K Nirmala Prasad, Independent Director of the Company, on 05 December 2019.

Cyient

Cyient announced that AnSem, a Cyient Company, has been selected to join the Arm Approved Design Partner program. The Arm Approved Design Partner program is a global network of design service companies endorsed by Arm, who can provide expert support during the development and manufacturing of Arm-based SoCs.

The recognition reaffirms Cyient's superior track record in embedding Arm-based processors and IP in larger SoCs and its strong internal quality assurance system, design flows, risk management procedures, and financial stability, critical to providing high-quality custom IC design and supply services.

AnSem is the center of excellence in Cyient for providing Custom Turnkey Mixed-Signal ASICs and managing the complete life cycle-from design requirements to high-volume production until endof- life. Being an Arm Approved Design Partner will provide AnSem with access to IP, tools, and technical support from Arm.

DCM Shriram

DCM Shriram has commissioned 200 KLD distillery at Ajbapur on 03 December 2019. The total capacity of the Company's distillery after the said commissioning now stands at 350 KLD.

Dynamic Portfol

Dynamic Portfolio Management & Services has appointed Neha Sharma (ACS 57676) as Company Secretary and Compliance Officer w.e.f 5 December,2019.

Enbee Trade

Enbee Trade & Finance will hold a meeting of the Board of Directors of the Company on 11 December 2019.

<< < 1 2 3   > >> 
 1860-3000-1099
 Customercare@bmastock.com
 +91 6289 900 971
  • Investors can lodge their complaints at investor.complaints@bmastock.com   SCOREs Portal
  • SEBI Regn. No : NSE: INZ000184733 | NSE FO : INZ000184733 | NSE CD: INZ000184733 | BSE: INZ000184733 | NCDEX : INZ000082232 |
    MCX : INZ000082232
  • Copyright © 2016 BRH WEALTH KREATORS LTD. All rights reserved Designed, developed & powered by CMOTS Infotech (ISO 9001:2015 certified)